These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1974 related items for PubMed ID: 22195744

  • 1. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.
    Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, McCormick LL, Fitzgerald P, Chi H, Munger J, Green DR.
    Immunity; 2011 Dec 23; 35(6):871-82. PubMed ID: 22195744
    [Abstract] [Full Text] [Related]

  • 2. Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent.
    Liu L, Lu Y, Martinez J, Bi Y, Lian G, Wang T, Milasta S, Wang J, Yang M, Liu G, Green DR, Wang R.
    Proc Natl Acad Sci U S A; 2016 Feb 09; 113(6):1564-9. PubMed ID: 26811453
    [Abstract] [Full Text] [Related]

  • 3. MYC and HIF in shaping immune response and immune metabolism.
    Gnanaprakasam JNR, Sherman JW, Wang R.
    Cytokine Growth Factor Rev; 2017 Jun 09; 35():63-70. PubMed ID: 28363691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X, Li J, Sun X, Guo Y, Chu D, Wei L, Li X, Yang G, Liu X, Yao L, Zhang J, Shen L.
    Oncotarget; 2015 Sep 22; 6(28):26161-76. PubMed ID: 26317652
    [Abstract] [Full Text] [Related]

  • 6. Glutathione Primes T Cell Metabolism for Inflammation.
    Mak TW, Grusdat M, Duncan GS, Dostert C, Nonnenmacher Y, Cox M, Binsfeld C, Hao Z, Brüstle A, Itsumi M, Jäger C, Chen Y, Pinkenburg O, Camara B, Ollert M, Bindslev-Jensen C, Vasiliou V, Gorrini C, Lang PA, Lohoff M, Harris IS, Hiller K, Brenner D.
    Immunity; 2017 Apr 18; 46(4):675-689. PubMed ID: 28423341
    [Abstract] [Full Text] [Related]

  • 7. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
    Caro-Maldonado A, Wang R, Nichols AG, Kuraoka M, Milasta S, Sun LD, Gavin AL, Abel ED, Kelsoe G, Green DR, Rathmell JC.
    J Immunol; 2014 Apr 15; 192(8):3626-36. PubMed ID: 24616478
    [Abstract] [Full Text] [Related]

  • 8. Metabolic regulation of osteoclast differentiation and function.
    Indo Y, Takeshita S, Ishii KA, Hoshii T, Aburatani H, Hirao A, Ikeda K.
    J Bone Miner Res; 2013 Nov 15; 28(11):2392-9. PubMed ID: 23661628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
    Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, Thompson CB.
    Proc Natl Acad Sci U S A; 2008 Dec 02; 105(48):18782-7. PubMed ID: 19033189
    [Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation.
    Marchingo JM, Sinclair LV, Howden AJ, Cantrell DA.
    Elife; 2020 Feb 05; 9():. PubMed ID: 32022686
    [Abstract] [Full Text] [Related]

  • 12. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
    Swamy M, Pathak S, Grzes KM, Damerow S, Sinclair LV, van Aalten DM, Cantrell DA.
    Nat Immunol; 2016 Jun 05; 17(6):712-20. PubMed ID: 27111141
    [Abstract] [Full Text] [Related]

  • 13. De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition.
    Tarrado-Castellarnau M, de Atauri P, Tarragó-Celada J, Perarnau J, Yuneva M, Thomson TM, Cascante M.
    Mol Syst Biol; 2017 Oct 04; 13(10):940. PubMed ID: 28978620
    [Abstract] [Full Text] [Related]

  • 14. MYC and tumor metabolism: chicken and egg.
    Dejure FR, Eilers M.
    EMBO J; 2017 Dec 01; 36(23):3409-3420. PubMed ID: 29127156
    [Abstract] [Full Text] [Related]

  • 15. MYC and metabolism on the path to cancer.
    Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang CV.
    Semin Cell Dev Biol; 2015 Jul 01; 43():11-21. PubMed ID: 26277543
    [Abstract] [Full Text] [Related]

  • 16. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
    Zhao X, Petrashen AP, Sanders JA, Peterson AL, Sedivy JM.
    Aging Cell; 2019 Jun 01; 18(3):e12947. PubMed ID: 30909319
    [Abstract] [Full Text] [Related]

  • 17. Yap-Myc signaling induces pancreatic stellate cell activation through regulating glutaminolysis.
    Zhang D, Zhao L, Luo M, Lei J, Shao S.
    Exp Cell Res; 2022 Feb 01; 411(1):113000. PubMed ID: 34958764
    [Abstract] [Full Text] [Related]

  • 18. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes.
    Verbist KC, Guy CS, Milasta S, Liedmann S, Kamiński MM, Wang R, Green DR.
    Nature; 2016 Apr 21; 532(7599):389-93. PubMed ID: 27064903
    [Abstract] [Full Text] [Related]

  • 19. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.
    Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM.
    Oncogene; 2009 Jul 09; 28(27):2485-91. PubMed ID: 19448666
    [Abstract] [Full Text] [Related]

  • 20. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
    Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H.
    J Exp Med; 2011 Jul 04; 208(7):1367-76. PubMed ID: 21708926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 99.